Radnostix Acquires Lucerno Dynamics Assets, Expanding Radiopharma Portfolio
INIS sits 55% above its 52-week low of $0.045.
Summary
Radnostix Inc. has acquired assets from Lucerno Dynamics, which will expand its radiopharma medical device portfolio. This news follows an 8-K filed yesterday, July 1st, which disclosed a strategic acquisition of the Lara System and Ellexa Explorer Software for up to $40 million. The acquisition is highly material, with a potential value exceeding the company's current market capitalization of approximately $37 million. This strategic move aims to bolster the company's product offerings, which is critical given its recent Q1 2026 financial results showing a wider net loss and lower revenue.
At the time of this announcement, INIS was trading at $0.07 on OTC in the Life Sciences sector, with a market capitalization of approximately $37M. The 52-week trading range was $0.05 to $0.11. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.